Corticosteroid Therapy for IBD: Old and New

Corticosteroid Therapy for IBD: Old and New

Bibliographic Details
Main Author:	Gordon R Greenberg
Format:	Article
Language:	English
Published:	Hindawi Limited 1993-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1993/473746

Similar Items

Bugs, TNF-α and IBD: More Fuel for the Fire
by: Gordon R Greenberg
Published: (2002-01-01)

Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment
by: Katarzyna Neubauer, et al.
Published: (2019-04-01)

Role of 5-ASA in IBD Therapy
by: CN Williams
Published: (1994-01-01)

Editorial: Microbiome in IBD: From Composition to Therapy
by: Ruixin Zhu, et al.
Published: (2021-06-01)

Role of immunosuppressive and biologic therapy in pediatric IBD
by: Nobile, Stefano <1978>
Published: (2012)

New IBD Markers: Definition of Disease Heterogeneity
by: Stephan R Targan
Published: (1995-01-01)

IBD or strongyloidiasis?
by: Marta Maia Boscá-Watts, et al.

IBD and Diet
by: Ilene Gilbert, et al.
Published: (1994-01-01)

Microbiota and IBD
by: B. Wu, et al.
Published: (2020-01-01)

Microbiota and IBD
by: M. Aberg, et al.
Published: (2020-06-01)

Factors Predicting the Adherence to the Therapy of Italian IBD Patients
by: Cristina Bucci, et al.
Published: (2017-01-01)

New Insights into the Role of Trace Elements in IBD
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2018-01-01)

IBD: Progress in Pathogenesis
by: Claudio Fiocchi, et al.
Published: (1993-01-01)

A Review of Dietary Therapy for IBD and a Vision for the Future
by: Nicole Green, et al.
Published: (2019-04-01)

IBD considerations in spondyloarthritis
by: Caroline Di Jiang, et al.
Published: (2020-07-01)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
by: Lorenz Bon, et al.
Published: (2019-01-01)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
by: Jessica Mwinyi, et al.
Published: (2012-01-01)

Lessons in IBD Pathogenesis from New Animal Models of Spontaneous Colitis
by: R Balfour Sartor
Published: (1995-01-01)

IS THERE RENAISSANCE OF CORTICOSTEROID THERAPY?
by: H Michels
Published: (2000-04-01)

Overcoming challenges in IBD management
by: B S Ramakrishna
Published: (2015-01-01)

Inclusion body disease (IBD)
by: Keilwerth, Melanie
Published: (2010)

IBD Epidemiology: Ongoing Issues and New Ideas. The Canadian Perspecitve
by: ABR Thomson
Published: (1993-01-01)

Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD
by: Gregor Jezernik, et al.
Published: (2020-11-01)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
by: Loris Riccardo Lopetuso, et al.
Published: (2020-06-01)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
by: Jihye Park, et al.
Published: (2021-09-01)

Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD
by: Gil Berkovitch, et al.
Published: (2021-02-01)

Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
by: Sara Deleu, et al.
Published: (2021-04-01)

Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy
by: Xuerui Zhang, et al.
Published: (2021-06-01)

Serial fecal biomarker measurements predict response to biologic therapy in children with IBD
by: Moxley, Erika Michelle
Published: (2019)

Endoscopic Optical Enhancement Technologies in IBD
by: Gian Eugenio Tontini, et al.
Published: (2013-11-01)

Diet and Nutrition in IBD—Progress and Gaps
by: Maitreyi Raman, et al.
Published: (2019-07-01)

Predicting Colorectal Cancer Occurrence in IBD
by: Mehmet Yalchin, et al.
Published: (2021-06-01)

Gut Serpinome: Emerging Evidence in IBD
by: Héla Mkaouar, et al.
Published: (2021-06-01)

Nutrition in Inflammatory Bowel Disease (IBD)
Published: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
by: Israr Khan, et al.
Published: (2019-08-01)

Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®
by: Jan de Laffolie, et al.
Published: (2017-01-01)

Children with inflammatory bowel disease (IBD) : finding strategies to cope with physical symptoms in school
by: Gordon, Maria
Published: (2004)

Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal
by: Anita Annaházi, et al.
Published: (2015-01-01)

A magic pill? A qualitative analysis of patients’ views on the role of antidepressant therapy in inflammatory bowel disease (IBD)
by: Mikocka-Walus Antonina A, et al.
Published: (2012-07-01)

Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
by: Gonzalo Saiz-Gonzalo, et al.
Published: (2021-07-01)